Sonoma Pharmaceuticals Inc (SNOA)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 03/31
(Values in U.S. thousands)
| 03-2026 | 03-2025 | 03-2024 | 03-2023 | 03-2022 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -3,175 | -3,457 | -4,835 | -5,151 | -5,086 |
| Depreciation Amortization | 139 | 138 | 176 | 125 | 186 |
| Income taxes - deferred | -231 | 357 | -109 | -37 | -829 |
| Accounts receivable | -122 | 434 | -230 | -4 | 1,971 |
| Accounts payable and accrued liabilities | 871 | 416 | -278 | -864 | -157 |
| Other Working Capital | -921 | 2,650 | 1,854 | -1,757 | 3,354 |
| Other Operating Activity | -494 | -626 | 1,024 | 1,536 | -3,687 |
| Operating Cash Flow | $-3,933 | $-88 | $-2,398 | $-6,152 | $-4,248 |
| Cash Flows From Investing Activities | |||||
| PPE Investments | -192 | -80 | -2 | -269 | -137 |
| Purchase Of Investment | N/A | N/A | N/A | 11 | 38 |
| Investing Cash Flow | $-192 | $-80 | $-2 | $-258 | $-99 |
| Cash Flows From Financing Activities | |||||
| Change In Short Term Borrowing | 277 | 274 | 373 | 515 | 123 |
| Debt Repayment | N/A | N/A | N/A | -120 | -467 |
| Common Stock Issued | 471 | 3,161 | 1,784 | 2,868 | 7,770 |
| Common Stock Repurchased | N/A | -1 | N/A | N/A | N/A |
| Other Financing Activity | -271 | -404 | -481 | -774 | -30 |
| Financing Cash Flow | $477 | $3,030 | $1,676 | $2,489 | $7,396 |
| Exchange Rate Effect | 673 | -616 | 32 | 345 | 127 |
| Beginning Cash Position | 5,374 | 3,128 | 3,820 | 7,396 | 4,220 |
| End Cash Position | 2,399 | 5,374 | 3,128 | 3,820 | 7,396 |
| Net Cash Flow | $-2,975 | $2,246 | $-692 | $-3,576 | $3,176 |
| Free Cash Flow | |||||
| Operating Cash Flow | -3,933 | -88 | -2,398 | -6,152 | -4,248 |
| Capital Expenditure | -192 | -80 | -2 | -269 | -137 |
| Free Cash Flow | -4,125 | -168 | -2,400 | -6,421 | -4,385 |